News
Lilly bags FDA okay for Wegovy pill rival orforglipron
Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
News
Agios mulls early FDA filing for sickle cell therapy
Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
News
FDA points to liver injury with Amgen's Tavneos
The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
News
NHS to offer Wegovy to a million more people in England
The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.
News
Novo hits back at rivals with cut-price Wegovy subscriptions
Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for Wegovy cash payers.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
